Okyanos Heart Institute Names Dr. Howard Walpole As Chief Medical Officer

AppId is over the quota
AppId is over the quota

    RALEIGH, NC, March 11, 2012 /24-7PressRelease/ -- Okyanos Heart Institute (http://www.okyanos.com/), which brings a new option, standard of care and quality of life to patients with coronary artery disease (CAD), has announced that Howard T. Walpole Jr., M.D., MBA, FACC, FACAI, will serve as the organization's Chief Medical Officer and Interventional Cardiologist. Walpole is a prominent cardiologist in the United States who in his 25 years of practice as a patient-centric physician has completed approximately 5,000 catheter-based interventions and 12,000 diagnostic catheterizations, as well as myocardial biopsies.

Previously, Walpole served as the Chief of Cardiac Sciences at St. Thomas Hospital in Nashville, Tenn., a medical center with 3,300 employees and a service population of approximately 2 million across three states. He led the strategy and operations of the Cardiac Sciences division, which included 37 cardiologists, five cardiac surgeons and nine cardiac anesthesiologists. Prior to that, Walpole was the managing partner of The Heart Group, PLLC, where he directed an operating budget of more than $20 million and led the growth strategy which expanded the practice from seven cardiologists to 37 and developed 15 new clinic locations in middle Tennessee and southern Kentucky.

A longtime member of the American Heart Association, Walpole served two terms as the president of the Davidson County, Tennessee Chapter from 1996-1997 and 2009-2010. Besides his present duties on the board of trustees through 2017, his participation in the American College of Cardiology includes working on the board of governors chair-elect nominating committee, co-chairing the "Evolving Models of Clinical Practice" from 2009-2010 and chairing the "Cardiovascular Care Summit" for 2012. Walpole received his Bachelor of Science from the University of Georgia, his M.D. from the Medical College of Georgia and his MBA from the Goizueta School of Business at Emory University in Georgia.

QUOTES:
"I am honored to serve Okyanos Heart Institute as it launches bringing a new standard of care and a better quality of life to patients with severe heart disease where bypass and stents are no longer viable treatment options," said Walpole. "Our medical practices combined with innovative research offer promising advances in cardiac care. I look forward to letting more people know about the advances in medicine that Okyanos has planned for the future."

NEW MEDIA CONTENT:
Okyanos LinkedIn Home page
http://www.linkedin.com/company/okyanos-heart-institute

DETAILS:
- In his leadership at Saint Thomas Hospital, Walpole drove successes in various areas of cardiac care, including developing the Therapeutic Hypothermia protocol of St. Thomas Hospital and its 14 hospital member Chest Pain Network, as well as instituting documentation for physicians that improved the severity of illness index by 6.3 percent and lowered the risk of mortality index by 12.5 percent.

- He also developed the Cardiac Sciences Leadership group at St. Thomas Hospital to coordinate operations across inpatient and outpatient cardiac services and taught EKG interpretation classes for the emergency department staff.

ABOUT OKYANOS HEART INSTITUTE:
Based in Freeport, The Bahamas, the Okyanos Heart Institute is a Center of Excellence (CoE) adhering to U.S. surgical center standards and led by Chief Medical Officer Dr. Howard (Bo) Walpole, a leader of the American College of Cardiology for many years. The Okyanos Heart Institute brings a new option, standard of care and quality of life to patients with coronary artery disease (CAD), utilizing an EU-approved cell therapy device. The Greek god of rivers, "Okyanos" symbolizes the primary mechanism of action that these adult stem cells have on ischemic (lack of blood flow) heart tissue, the result of the plaque deposits in the coronary arteries. The cells, derived from a person's adipose (fat) tissue, create new blood vessels, a process known as angiogenesis. The cells facilitate blood flow in the heart and intake and use of oxygen, as measured by a rigorous clinical trial known as the PRECISE trial, as well as cardiac cell-therapy trials at leading research institutions including Texas Heart Institute, and University of Miami. For more information, visit http://www.okyanos.com/.

Anjelica Cummings
MMI Public Relations
(919) 233-6600
anjelica@mmipublicrelations.com
http://twitter.com/MMIPR
http://www.mmipublicrelations.com

(end)

---
Press release service and press release distribution provided by http://www.24-7pressrelease.com

# # #

Read more Press Releases from Patty Briguglio:

View the original article here

The Institute Now Offers Clear + Brilliant Laser

The remote server returned an unexpected response: (417) Expectation failed.
The remote server returned an unexpected response: (417) Expectation failed.

The Institute Adds Non-surgical Option to Facelift
    MARINA DEL REY, CA, March 31, 2012 /24-7PressRelease/ -- To help prevent aging and enhance the skin's radiance, Dr. Grant Stevens of The Institute at Marina Plastic Surgery recently added the new Clear + Brilliant laser system to the medical spa's facial rejuvenation menu. The Institute offers a full range of non-surgical cosmetic treatments, such as laser hair removal in Los Angeles and BOTOX Cosmetic.

"I chose the Clear + Brilliant laser system because many of our patients who are in their 20s and 30s want to target those initial signs of aging, such as uneven tone and texture," Dr. Stevens says, " but they don't need dramatic changes, such as a facelift. Los Angeles is an appearance-conscious society, however, and they're smart in recognizing that having glowing, healthy skin can enhance their lives both professionally and personally.

"That's where Clear + Brilliant is ideal. It offers a no-downtime way to gently resurface areas of damaged skin and maintain healthy skin."

The Clear + Brilliant laser treatment is fast and effective. One of The Institute's skin specialists first evaluates the patient's skin to determine which laser level will be appropriate. During the 20-to-30-minute procedure, the device's patented Intelligent Optical Tracking System (IOTS ) delivers carefully measured laser energy to the skin to gently resurface it.

"I'm very pleased with the flexibility of this new system and the results we're seeing," Dr. Stevens says. "In addition to maintaining or restoring younger patients' smoothly textured and toned skin, the Clear + Brilliant system is excellent for patients of all ages who require only moderate treatment to achieve radiant skin.

"Because we have so many options for rejuvenating our patients' skin, we can combine this laser system with other procedures. I take pride in the way we can customize each patient's treatment so that it achieves their goals."

The medical director of Marina Plastic Surgery Associates, Dr. Stevens founded The Stevens Institute because he recognized a need for professional skin care both before and after surgery. Research shows that the best surgical results are attained when the skin is at its optimal state of health.

By creating The Institute at Marina Plastic Surgery, Dr. Stevens says he can offer his patients "the opportunity to tap into the best of both worlds: plastic surgery for those who want or need more dramatic, permanent changes; and non-surgical rejuvenation treatments for those who desire no-downtime enhancements."

"In addition," he says, "we can deliver a combination of the two for those who want a more complete transformation."

Dr. Grant Stevens is medical director of Marina Plastic Surgery Associates (www.marinaplasticsurgery.com) in Marina Del Rey, CA and founder of The Stevens Institute. He is a diplomate of the American Board of Plastic Surgery and a fellow of The American College of Surgeons and The International College of Surgeons. Dr. Stevens is the director of the USC Aesthetic Surgery Fellowship.

---
Press release service and press release distribution provided by http://www.24-7pressrelease.com

# # #

Press Release Keywords:

Read more Press Releases from Grant Stevens:

View the original article here

Okyanos Heart Institute Names Dr. Howard Walpole As Chief Medical Officer

The remote server returned an unexpected response: (417) Expectation failed.
The remote server returned an unexpected response: (417) Expectation failed.

    RALEIGH, NC, March 11, 2012 /24-7PressRelease/ -- Okyanos Heart Institute (http://www.okyanos.com/), which brings a new option, standard of care and quality of life to patients with coronary artery disease (CAD), has announced that Howard T. Walpole Jr., M.D., MBA, FACC, FACAI, will serve as the organization's Chief Medical Officer and Interventional Cardiologist. Walpole is a prominent cardiologist in the United States who in his 25 years of practice as a patient-centric physician has completed approximately 5,000 catheter-based interventions and 12,000 diagnostic catheterizations, as well as myocardial biopsies.

Previously, Walpole served as the Chief of Cardiac Sciences at St. Thomas Hospital in Nashville, Tenn., a medical center with 3,300 employees and a service population of approximately 2 million across three states. He led the strategy and operations of the Cardiac Sciences division, which included 37 cardiologists, five cardiac surgeons and nine cardiac anesthesiologists. Prior to that, Walpole was the managing partner of The Heart Group, PLLC, where he directed an operating budget of more than $20 million and led the growth strategy which expanded the practice from seven cardiologists to 37 and developed 15 new clinic locations in middle Tennessee and southern Kentucky.

A longtime member of the American Heart Association, Walpole served two terms as the president of the Davidson County, Tennessee Chapter from 1996-1997 and 2009-2010. Besides his present duties on the board of trustees through 2017, his participation in the American College of Cardiology includes working on the board of governors chair-elect nominating committee, co-chairing the "Evolving Models of Clinical Practice" from 2009-2010 and chairing the "Cardiovascular Care Summit" for 2012. Walpole received his Bachelor of Science from the University of Georgia, his M.D. from the Medical College of Georgia and his MBA from the Goizueta School of Business at Emory University in Georgia.

QUOTES:
"I am honored to serve Okyanos Heart Institute as it launches bringing a new standard of care and a better quality of life to patients with severe heart disease where bypass and stents are no longer viable treatment options," said Walpole. "Our medical practices combined with innovative research offer promising advances in cardiac care. I look forward to letting more people know about the advances in medicine that Okyanos has planned for the future."

NEW MEDIA CONTENT:
Okyanos LinkedIn Home page
http://www.linkedin.com/company/okyanos-heart-institute

DETAILS:
- In his leadership at Saint Thomas Hospital, Walpole drove successes in various areas of cardiac care, including developing the Therapeutic Hypothermia protocol of St. Thomas Hospital and its 14 hospital member Chest Pain Network, as well as instituting documentation for physicians that improved the severity of illness index by 6.3 percent and lowered the risk of mortality index by 12.5 percent.

- He also developed the Cardiac Sciences Leadership group at St. Thomas Hospital to coordinate operations across inpatient and outpatient cardiac services and taught EKG interpretation classes for the emergency department staff.

ABOUT OKYANOS HEART INSTITUTE:
Based in Freeport, The Bahamas, the Okyanos Heart Institute is a Center of Excellence (CoE) adhering to U.S. surgical center standards and led by Chief Medical Officer Dr. Howard (Bo) Walpole, a leader of the American College of Cardiology for many years. The Okyanos Heart Institute brings a new option, standard of care and quality of life to patients with coronary artery disease (CAD), utilizing an EU-approved cell therapy device. The Greek god of rivers, "Okyanos" symbolizes the primary mechanism of action that these adult stem cells have on ischemic (lack of blood flow) heart tissue, the result of the plaque deposits in the coronary arteries. The cells, derived from a person's adipose (fat) tissue, create new blood vessels, a process known as angiogenesis. The cells facilitate blood flow in the heart and intake and use of oxygen, as measured by a rigorous clinical trial known as the PRECISE trial, as well as cardiac cell-therapy trials at leading research institutions including Texas Heart Institute, and University of Miami. For more information, visit http://www.okyanos.com/.

Anjelica Cummings
MMI Public Relations
(919) 233-6600
anjelica@mmipublicrelations.com
http://twitter.com/MMIPR
http://www.mmipublicrelations.com

(end)

---
Press release service and press release distribution provided by http://www.24-7pressrelease.com

# # #

Read more Press Releases from Patty Briguglio:

View the original article here